The impact of antiretroviral treatment on mortality trends of HIV‐positive adults in rural Uganda: a longitudinal population‐based study, 1999–2009

Objective  To investigate trends in all‐cause adult mortality after the roll‐out of an antiretroviral therapy (ART) programme in rural Uganda. Methods  Longitudinal population‐based cohort study of approximately 20 000 residents in rural Uganda. Mortality in adults aged 15–59 years was determined fo...

Full description

Saved in:
Bibliographic Details
Published in:Tropical medicine & international health 2012-08, Vol.17 (8), p.e66-e73
Main Authors: Kasamba, Ivan, Baisley, Kathy, Mayanja, Billy N., Maher, Dermot, Grosskurth, Heiner
Format: Article
Language:English
Subjects:
Adolescent
Adult
Age Distribution
Alpha Supplement
Anti-Retroviral Agents - therapeutic use
Antiretroviral drugs
antiretroviral therapy
CD4 Lymphocyte Count
Counseling
Female
HIV
HIV Infections - drug therapy
HIV Infections - mortality
HIV Seropositivity - drug therapy
HIV Seropositivity - mortality
Human immunodeficiency virus
Humans
Impact analysis
Longitudinal Studies
Male
Masaka
Middle Aged
Mortality
Mortality - trends
Rural Population - statistics & numerical data
Sex Distribution
Trends
Uganda
Uganda - epidemiology
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective  To investigate trends in all‐cause adult mortality after the roll‐out of an antiretroviral therapy (ART) programme in rural Uganda. Methods  Longitudinal population‐based cohort study of approximately 20 000 residents in rural Uganda. Mortality in adults aged 15–59 years was determined for the 5‐year period (1999–2003) before introduction of ART in January 2004 and for the 5‐year period afterwards. Poisson regression was used to estimate mortality rate ratios (RRs) for the period before ART, 1 year after ART introduction (from January 2004 to January 2005) and more than 1 year after ART introduction. Trends in mortality were analysed by HIV status, age and sex. Results  Before ART became available, the mortality rate (deaths per 1000 person‐years) was 4.0 (95% CI = 3.3–4.8) among HIV‐negative individuals and 116.4 (95% CI = 101.9–133.0) among HIV‐positive individuals. During the period January 2004–end November 2009, 279 individuals accessed ART. In the year after ART was introduced, the mortality rate (deaths per 1000 person‐years) among HIV‐negative individuals did not change significantly (adjusted RR = 0.95, 95% CI = 0.61–1.47), but among HIV‐positive individuals dropped by 25% to 87.4 (adjusted RR = 0.75, 95% CI = 0.53–1.06). In the period 2005–2009, the mortality rate (deaths per 1000 person‐years) among HIV‐positive individuals fell further to 39.9 (adjusted RR = 0.33, 95% CI = 0.26–0.43). The effect was greatest among individuals aged 30–44 years, and trends were similar in men and women. Conclusion  The substantially reduced mortality rate among HIV‐positive individuals after ART roll‐out lends further support to the intensification of efforts to ensure universal access to ART.
ISSN:1360-2276
1365-3156
DOI:10.1111/j.1365-3156.2012.02841.x